E Nettis-Eustachio

Bari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 173 publications

Between hypersensitivity and toxicity: the complex spectrum of chemotherapy-induced skin reactions.

Between hypersensitivity and toxicity: the complex spectrum of chemotherapy-induced skin reactions.

Journal: Current opinion in allergy and clinical immunology

Published: August 22, 2026

Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

Journal: The British journal of dermatology

Published: May 16, 2026

Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis - A Single-Center Retrospective Longitudinal Study.

Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis - A Single-Center Retrospective Longitudinal Study.

Journal: Indian journal of dermatology

Published: May 11, 2026

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Journal: Dermatology and therapy

Published: March 17, 2026

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Journal: Biomedicines

Published: February 12, 2026

Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patients.

Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patients.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 21, 2025

Effectiveness and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Associated T2 Comorbidities: One-Year Real Life Round.

Effectiveness and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Associated T2 Comorbidities: One-Year Real Life Round.

Journal: Journal of clinical medicine

Published: December 10, 2025

Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.

Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: November 07, 2025

Long-Term Effectiveness of Dupilumab in Eosinophilic Esophagitis: Results From the DUPEOETALY Study.

Long-Term Effectiveness of Dupilumab in Eosinophilic Esophagitis: Results From the DUPEOETALY Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 19, 2025

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Journal: Allergy

Published: October 15, 2025

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Journal: Allergy

Published: October 15, 2025

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Journal: Allergy

Published: October 15, 2025

Showing 1-12 of 173

Last Updated: 09/26/2026